Bottom line
PBE vs HTEC: the short answer
PBE (Invesco Biotechnology & Genome ETF) and HTEC (ROBO Global(R) Healthcare Technology and Innovation ETF) are both etfs.
PBE is cheaper at 0.59% vs 0.68% — a difference of $9.00 a year per $10,000 invested.
Over five years, PBE returned +3.4% a year vs −3.9% for HTEC.
Updated Nov 19, 2026
PBE vs HTEC side by side
| PBE | HTEC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | Innovator |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.59% | 0.68% |
| Annual cost per $10k | $59 | $68 |
| 10-yr cost on $10k (prospectus) | $738 | $979 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +24.7% | +24.0% |
| 5-yr return (annualized) | +3.4% | −3.9% |
| 10-yr return (annualized) | +5.2% | — |
| Best quarter | +25.3% | +30.7% |
| Worst quarter | −24.3% | −20.8% |
| Net assets (fund) | $281.9M | $69.1M |
| Number of holdings | 33 | 63 |
| Portfolio turnover | 103% | 38% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PBE | HTEC | Difference |
|---|---|---|---|
| 2025 | +24.7% | +24.0% | +0.7% |
| 2024 | +1.1% | +2.8% | −1.7% |
| 2023 | +3.7% | −3.0% | +6.7% |
| 2022 | −10.8% | −33.6% | +22.8% |
| 2021 | +1.6% | −0.2% | +1.8% |
| 2020 | +25.5% | +65.2% | −39.7% |
Source: Fund prospectus bar charts
Holdings overlap
5 of PBE's top 25 holdings also appear in HTEC's top 25.
| Holding | PBE | HTEC |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 5.47% | 1.97% |
| CareDx, Inc. | 5.04% | 2.68% |
| Vertex Pharmaceuticals Inc. | 4.99% | 1.91% |
| Illumina, Inc. | 3.51% | 2.09% |
| Incyte Corp. | 3.06% | 1.80% |
Source: SEC Form N-PORT
PBE top 10
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Vertex Pharmaceuticals Inc. — 4.99%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Gilead Sciences, Inc. — 4.43%
- United Therapeutics Corp. — 4.08%
HTEC top 10
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Natera, Inc. — 2.23%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Medpace Holdings, Inc. — 2.12%
- Adaptive Biotechnologies Corporation — 2.11%
- Iqvia Holdings Inc — 2.10%
- Illumina, Inc. — 2.09%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
FAQ
What is the difference between PBE and HTEC?
Which is cheaper, PBE or HTEC?
Should I own both PBE and HTEC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.